tiprankstipranks

Michael Cola Insider Profile

4 Followers
Michael Cola, Director at Phathom Pharmaceuticals, holds 63.92K shares in Phathom Pharmaceuticals (Ticker: PHAT), holds 175.75K shares in Avalo Therapeutics (Ticker: AVTX), holds 2.27M shares in Aevi Genomic Medicine (Ticker: ~GNMX).
tipranks
Michael Cola

Michael Cola
Phathom Pharmaceuticals (PHAT)
Director

Ranked #23,540 out of 108,921 Corporate Insiders

Profitable Transactions

50%
3 out of 6 Profitable Transactions

Average Return

+11.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$4M
83.54%
14.54%
1.93%
A breakdown of Michael Cola's holdings

Insider Roles

Avalo Therapeutics
(AVTX)
CEO, Director
Phathom Pharmaceuticals
(PHAT)
Director
Vanda
(VNDA)
Director
Roles that Michael Cola holds in companies

Most Profitable Insider Trade

Stock:
Aevi Genomic Medicine
(~GNMX)
Rating:Informative Buy
Date:Dec 01, 2014 - Dec 01, 2015
Return:+61.90%
The most profitable trade made by Michael Cola

Michael Cola's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Phathom Pharmaceuticals
May 21, 2026
Director
Uninformative Buy
$602.77K
Avalo Therapeutics
Jun 11, 2020
CEO, Director
Informative Buy
250.00K
$3.46M
~GNMX
Aevi Genomic Medicine
Dec 09, 2019
Informative Buy
266.42K
$526.14K
Vanda
Jun 17, 2019
Director
Uninformative Buy
$79.95K
SAGE
SAGE Therapeutics
$0.00
~PATH
Nupathe Inc
Feb 25, 2014
Uninformative Sell
91.80K
List of latest transactions for each holding click on a transaction to see Michael Cola's performance on stock

Michael Cola insider profile FAQ

What is the percentage of profitable transactions made by Michael Cola?
The percentage of profitable transactions made by Michael Cola is 50%.
    What is the average return per transaction made by Michael Cola?
    The average return per transaction made by Michael Cola is 11.80%.
      What stocks does Michael Cola hold?
      Michael Cola holds: PHAT, AVTX, ~GNMX, VNDA, SAGE, ~PATH stocks.
        What was Michael Cola’s latest transaction?
        Michael Cola latest transaction was an Uninformative Buy of ―.
          What was Michael Cola's most profitable transaction?
          Michael Cola’s most profitable transaction was an Informative Buy of ~GNMX stock on December 1, 2014. The return on the trade was 61.90%.
            What is Michael Cola's role in Phathom Pharmaceuticals?
            Michael Cola's role in Phathom Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.